The absence of the cataract makes the distinction between the two clinical variants of RTS: the form with poikiloderma and ocular defects, named RTSI, and poikiloderma, skeleton defects, predisposition to cancer and RECQL4 mutations, named RTSII, which accounts for approximately 66% of RTS patients (Table 1). This evidence concerns the gene RECQL4 and cancer.